A
Arnas Rakauskas
Researcher at University Hospital of Lausanne
Publications - 30
Citations - 303
Arnas Rakauskas is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 3, co-authored 8 publications receiving 126 citations.
Papers
More filters
Journal ArticleDOI
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies
Giorgio Gandaglia,Guillaume Ploussard,Massimo Valerio,Agostino Mattei,Cristian Fiori,Nicola Fossati,Armando Stabile,Jean Baptiste Beauval,Bernard Malavaud,Mathieu Roumiguié,Daniele Robesti,Paolo Dell'Oglio,Marco Moschini,Stefania Zamboni,Arnas Rakauskas,Francesco De Cobelli,Francesco Porpiglia,Francesco Montorsi,Alberto Briganti +18 more
TL;DR: The first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy is developed.
Journal ArticleDOI
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Giorgio Gandaglia,Guillaume Ploussard,Massimo Valerio,Agostino Mattei,Cristian Fiori,Mathieu Roumiguié,Nicola Fossati,Armando Stabile,Jean Baptiste Beauval,Bernard Malavaud,Simone Scuderi,Francesco Barletta,Marco Moschini,Stefania Zamboni,Arnas Rakauskas,Zhe Tian,Pierre I. Karakiewicz,Francesco De Cobelli,Francesco Porpiglia,Francesco Montorsi,Alberto Briganti +20 more
TL;DR: The combination of multiparametric magnetic resonance imaging with accurate biopsy information on MRI-targeted and systematic biopsies improves the accuracy of multivariable models based on clinical and mp-MRI data alone.
Journal ArticleDOI
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Giorgio Gandaglia,Guillaume Ploussard,Massimo Valerio,Giancarlo Marra,Marco Moschini,Alberto Martini,Mathieu Roumiguié,Nicola Fossati,Armando Stabile,Jean-Baptiste Beauval,Bernard Malavaud,Simone Scuderi,Francesco Barletta,Luca Afferi,Arnas Rakauskas,Paolo Gontero,Agostino Mattei,Francesco Montorsi,Alberto Briganti +18 more
TL;DR: The adoption of predictive models accounting for mpMRI and MRI-targeted biopsy-derived variables and concomitant systematic biopsy would improve clinicians' ability to identify patients at a higher risk of early recurrence after surgery.
Journal ArticleDOI
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Deepika Reddy,M. Peters,Taimur T. Shah,Marieke J. van Son,Mariana Tanaka,Philipp M. Huber,Derek Lomas,Arnas Rakauskas,Saiful Miah,David Eldred-Evans,Stephanie Guillaumier,Feargus Hosking-Jervis,R. Engle,Tim Dudderidge,Richard Hindley,A. Emara,Rajni Nigam,Neil McCartan,Massimo Valerio,Naveed Afzal,H.J.E. Lewi,Clement Orczyk,Chris Ogden,Iqbal S. Shergill,Rajendra Prasad,Jaspal Virdi,Caroline M. Moore,Manit Arya,Mathias Winkler,Mark Emberton,Hashim U. Ahmed +30 more
TL;DR: Focal high-intensity focused ultrasound (HIFU) was used to treat non-metastatic prostate cancer as mentioned in this paper , which achieved good medium-term cancer control over 7 years, although 10-yr data are not available.
Journal ArticleDOI
Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
Nagjie Alijaj,Blaz Pavlovic,P. Martel,Arnas Rakauskas,Valérie Cesson,Karim Saba,T. Hermanns,Pascal Oechslin,Markus Veit,Maurizio Provenzano,Jan H. Rüschoff,Muriel Brada,Niels J. Rupp,Cédric Poyet,Laurent Derré,Massimo Valerio,Irina Banzola,Daniel Eberli +17 more
TL;DR: This study identified and validated novel urine biomarkers for the screening of PCa, showing that an upfront urine test, based on quantitative biomarkers and patient age, is a feasible method to reduce the number of unnecessary prostate biopsies and detect both healthy men and clinically significant PCa.